Proinflammatory molecules, such as interleukins (IL-1β, IL-6 and IL-8), inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-α), responsible for the initiation and maintenance of chronic joint inflammation were also targeted [41,42]. The gene discussed is NOS2; the disease is inflammation.